Gustavo Dziewczapolski, Scientific Director5 days ago2 minOne Step Closer to LAMA2-RD Clinical Trials: Modalis TherapeuticsModalis Therapeutics program for LAMA2-RD gene therapy granted Rare Pediatric Disease Designation by FDA.